However, the continuous increase of RPE atrophy detected by polarization-sensitive OCT emphasizes the need for a tight assessment of treatment indication for anti-VEGF therapy in neovascular AMD (avoiding unnecessary therapeutic interventions) to balance benefit and risk. This evidence concerns the gene VEGFA and Atrophy.